Live Breaking News & Updates on ஆர்ஃபந் ப்ராடக்ட்ஸ்

Stay updated with breaking news from ஆர்ஃபந் ப்ராடக்ட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DBusiness Daily Update: Pincanna Opens Cannabis Retail Shop in East Lansing, and More

DBusiness Daily Update: Pincanna Opens Cannabis Retail Shop in East Lansing, and More
dbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dbusiness.com Daily Mail and Mail on Sunday newspapers.

East Lansing , United States , Ohair Park , Oakland County , Grand Rapids , Oakland Community College , Grand River , Foster Willey , Lila Neuenfelt , Robert Nusbaum , Sarahe Ray , Ruma Sharma , Anna Vitelli , Diana Sieger , Mike Duggan , Fannieb Peck , Dave Coulter , Rosalind Brewer , Carole Brown , Herstory Hall , Don Heberle , Jennifer Llewellyn , Debra White , Lina Gerchak , Carolyn Cassin , Holdings Inc ,

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

Share this article
Share this article
TEL AVIV, Israel and RALEIGH, NC, May 26, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced receipt of two Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) covering opaganib
[1] and RHB-107 (upamostat)
[2] as methods for the treatment of COVID-19 caused by the SARS-CoV-2 virus.
Both opaganib and RHB-107 are novel COVID-19 therapeutic candidates, in oral pill form, with dual mechanism of action effects. Both are host-targeted and are therefore expected to be effective against emerging viral variants with various mutations in the spike protein. ....

Hong Kong , United Kingdom , Macau General , Amber Fennell , Daniellet Abramson , Bryan Gibbs , Redhill Biopharma , Adi Frish , Opaganib Yeliva , Us Department Of Defense , Us National Institute Of Health , Apogee Biotechnology Corp , Redhill Biopharma Ltd , Exchange Commission , Company Annual Report On Form , Trademark Office , Company Expanded Access Program , Property Research At Redhill , Corporate Business Development , Germany Heidelberg Pharmaceuticals , Office Of Orphan Products Development , Prnewswire Redhill Biopharma Ltd , Hill Biopharma , Intellectual Property , Patent Cooperation Treaty , Orphan Drug ,

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United Kingdom , Macau General , Amber Fennell , Daniellet Abramson , Bryan Gibbs , Redhill Biopharma , Adi Frish , Opaganib Yeliva , Us Department Of Defense , Us National Institute Of Health , Apogee Biotechnology Corp , Redhill Biopharma Ltd , Exchange Commission , Company Annual Report On Form , Company Expanded Access Program , Property Research At Redhill , Corporate Business Development , Germany Heidelberg Pharmaceuticals , Office Of Orphan Products Development , Intellectual Property , Patent Cooperation Treaty , Orphan Drug , Orphan Products , Heidelberg Pharmaceuticals , Hill Biopharma ,

RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

(1)
Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients
The 464-patient global Phase 2/3 COVID-19 study is over 75% enrolled, with completion of enrollment expected in the coming weeks
Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication
TEL AVIV, Israel and RALEIGH, N.C., April 9, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva ....

United Kingdom , Amber Fennell , Bryan Gibbs , Redhill Biopharma , Adi Frish , Markl Levitt , Opaganib Yeliva , Us Department Of Defense , Us National Institute Of Health , Apogee Biotechnology Corp , Redhill Biopharma Ltd , Exchange Commission , Company Annual Report On Form , Company Expanded Access Program , Corporate Business Development , Office Of Orphan Products Development , U Apogee Biotechnology Corp , Prnewswire Redhill Biopharma Ltd , Independent Data Safety Monitoring Board , Hill Biopharma , Data Safety Monitoring Board , Medical Director , Expanded Access , Orphan Drug , Apogee Biotechnology , Orphan Products ,

RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Amber Fennell , Bryan Gibbs , Redhill Biopharma , Adi Frish , Markl Levitt , Opaganib Yeliva , Us Department Of Defense , Us National Institute Of Health , Apogee Biotechnology Corp , Redhill Biopharma Ltd , Exchange Commission , Company Annual Report On Form , Company Expanded Access Program , Corporate Business Development , Office Of Orphan Products Development , U Apogee Biotechnology Corp , Prnewswire Redhill Biopharma Ltd , Hill Biopharma , Data Safety Monitoring Board , Medical Director , Expanded Access , Orphan Drug , Apogee Biotechnology , Orphan Products , Private Securities Litigation Reform Act ,